Zinc finger protein 667 expression is upregulated by cerebral ischemic preconditioning and protects cells from oxidative stress.

Brain ischemic injury is associated with clinical emergencies such as acute ischemic and hemorrhagic stroke, head trauma, prolonged severe hypotension and cardiac arrest. Ischemic preconditioning (IPC) is the most powerful endogenous mechanism against ischemic injury. However, the majority of IPC treatments are invasive and thus impractical in the clinical setting. Identifying the endogenous neuroprotective mechanism induced by IPC is important for developing new strategies to reduce stroke severity. Zinc finger protein 667 (ZNF667) is a novel zinc finger protein that is upregulated by myocardial IPC. However, its functional role in neuronal ischemia has not been elucidated. In this study, the changes of ZNF667 expression on cerebral IPC and its potential neuroprotective function were investigated. The cerebral ischemia model was established by ameliorated four-vessel occlusion in rats. The northern blot results demonstrated that ZNF667 expression was increased in the hippocampus and cortex at 12 and 24 h after cerebral ischemic pretreatment. To investigate the neuroprotective function of ZNF667, enhanced green fluorescent protein (EGFP)-ZNF667 fusion protein was expressed in C2C12 and brain astrocytoma cells and its subcellular localization was detected by confocal microscopy. EGFP-ZNF667 fusion proteins were localized in the nucleus of C2C12 and brain astrocytoma cells, indicating that ZNF667 may act as a transcription factor in neural cells. To mimic oxidative stress associated with ischemia/reperfusion injury, hydrogen peroxide (H2O2) was used to treat cells. Cell viability was measured by the lactate dehydrogenase (LDH) and WST-1 assays. A decrease in viability was detected in C2C12 and astrocytoma cells following H2O2 treatment, whereas ZNF667 gene overexpression significantly improved cell viability following H2O2 treatment. These results suggested that ZNF667 plays a neuroprotective role by acting as a transcription factor in cerebral IPC.

[1]  D. Tang,et al.  Functional analysis of a novel KRAB/C2H2 zinc finger protein Mipu1. , 2007, Biochemical and biophysical research communications.

[2]  A Klug,et al.  Zinc fingers , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  O. Maksimenko,et al.  Cys2His2 zinc finger protein family: Classification, functions, and major members , 2012, Biochemistry (Moscow).

[4]  J. Brierley,et al.  A New Model of Bilateral Hemispheric Ischemia in the Unanesthetized Rat , 1979, Stroke.

[5]  C. Harrington,et al.  For Personal Use. Only Reproduce with Permission from the Lancet , 2022 .

[6]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[7]  J. Bonventre,et al.  The Krüppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Barone Endogenous brain protection: models, gene expression, and mechanisms. , 2005, Methods in molecular medicine.

[9]  E. Park,et al.  Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1β and IL-1 receptor antagonist in the ischemic cortex , 2009, Journal of Neuroimmunology.

[10]  Raul Urrutia,et al.  KRAB-containing zinc-finger repressor proteins , 2003, Genome Biology.

[11]  R. Vemuganti,et al.  Putative endogenous mediators of preconditioning‐induced ischemic tolerance in rat brain identified by genomic and proteomic analysis , 2004, Journal of neurochemistry.

[12]  S. Cuzzocrea,et al.  Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. , 2001, Pharmacological reviews.

[13]  M. R. Adams,et al.  Comparative genomics of the eukaryotes. , 2000, Science.

[14]  Youn Jung Kim,et al.  Mechanisms and Prospects of Ischemic Tolerance Induced by Cerebral Preconditioning , 2010, International neurourology journal.

[15]  Ruo-Pan Huang,et al.  Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation , 1998, Cell Death and Differentiation.

[16]  John Calvin Reed,et al.  Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. , 2000, Science.

[17]  F. Nicoletti,et al.  An enhanced expression of the immediate early gene, Egr-1, is associated with neuronal apoptosis in culture , 1999, Neuroscience.

[18]  C. Thompson,et al.  Regulation of expression of early growth response transcription factors in rat primary cortical neurons by extracellular ATP , 2006, Brain Research.

[19]  R. Simon,et al.  Genomics of Preconditioning , 2004, Stroke.

[20]  F. Barone Endogenous brain protection: models, gene expression, and mechanisms. , 2005, Methods in molecular medicine.

[21]  A. Majid,et al.  Ischemia and ischemic tolerance in the brain: an overview. , 2004, Neurotoxicology.

[22]  H. Aburatani,et al.  Genome-Wide Gene Expression Analysis for Induced Ischemic Tolerance and Delayed Neuronal Death following Transient Global Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  C. Mathers,et al.  Preventing stroke: saving lives around the world , 2007, The Lancet Neurology.